Biotechnology Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer’s, Shifts Focus On Newer Medicines – Biogen (NASDAQ:BIIB) Read more
Biotechnology New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval – Tonix Pharmaceuticals (NASDAQ:TNXP) Read more
Stockmarkets Brazil’s Gol wins court approval to access part of $950 million in financing Reuters via biedexmarkets.com Read more
Biotechnology Regeneron/Sanofi’s Largest Selling Drug Dupixent Scores FDA Approval For Infants With Esophagus Inflammation – Regeneron Pharmaceuticals (NASDAQ:REGN), Sanofi (NASDAQ:SNY) Read more